According to GuruFocus list of 52-week highs, Kroger Co, Covidien PLC, Valeant Pharmaceuticals International Inc, and Northrop Grumman Corp have all reached their 52-week highs.
Kroger Co (KR, Financial) Reached the 52-Week High of $69.05
Kroger Co operates retail food and drug stores, multi-department stores, jewelry stores, and convenience stores throughout the United States. Kroger Co has a market cap of $31.55 billion; its shares were traded at around $69.05 with a P/E ratio of 21.40 and P/S ratio of 0.33. The dividend yield of Kroger Co stocks is 0.98%. Kroger Co had an annual average earnings growth of 8.90% over the past 10 years. GuruFocus rated Kroger Co the business predictability rank of 4.5-star.
Kroger Co. has released its third quarter 2014 results. Same store sales growth without fuel was 5.6%, driving earnings growth to $362 million ($0.73 per diluted share), compared with $299 million ($0.57 per share) in the same quarter last year. Total sales increased 11.2% to $25.0 billion.
Covidien PLC (COV, Financial) Reached the 52-Week High of $106.71
Covidien PLC was incorporated in Bermuda in 2000 as a wholly-owned subsidiary of Tyco International Ltd. The company has a market cap of $46.31 billion; its shares were traded at around $106.71 with a P/E ratio of 27.50 and P/S ratio of 4.55. The dividend yield of Covidien Plc stocks is 1.30 and it had an annual average earnings growth of 7.30% over the past 10 years. GuruFocus rated Covidien Plc the business predictability rank of 2-star.
Covidien recently released its first quarter 2015 earnings results. First quarter sales increased 2% to $2.69 billion, and the company reported diluted GAAP EPS of $1.12, versus $0.87 for the same quarter last year. Net income was $511 million compared to $398 million a year ago.
Valeant Pharmaceuticals International Inc (VRX, Financial) Reached the 52-Week High of $159.97
Valeant Pharmaceuticals International Inc has a market cap of $48.04 billion; its shares were traded at around $159.97 with a P/E ratio of 126.30 and P/S ratio of 7.83. Valeant Pharmaceuticals International Inc had an annual average earnings growth of 3.70% over the past 10 years.
For its third quarter of 2014, Valeant Pharmaceuticals generated total revenues of $2.1 billion – an increase of 33% year-over-year. Same store organic growth of 19%, and adjusted operating cash flow increased 89% to $771 million. GAAP EPS for the quarter was $0.81.
Northrop Grumman Corp (NOC, Financial) Reached the 52-Week High of $156.95
Northrop Grumman Corp has a market cap of $29.77 billion; its shares were traded at around $156.95 with a P/E ratio of 16.10 and P/S ratio of 1.39. The dividend yield of Northrop Grumman Corp stocks is 1.73%. Northrop Grumman Corp had an annual average earnings growth of 10.90% over the past 10 years.
In its fourth quarter of 2014, the company generated EPS of $2.48, an increase of 17% over the prior year quarter. Total sales were $6.1 billion and free cash flow was $1.2 billion.
Check out the complete list of 52-Week Highs.
